Live Terminal
Telegram

Alkem Labs' Q2 net profit falls 14% to Rs 667 crore, shares decline 3%

Share on WhatsApp Telegram
⚡ Instant Key Takeaways (TL;DR)
🎯
Core Development: Alkem Labs' Q2 net profit falls 14% to Rs 667 crore, shares decline 3%
📊
Market & Financial Impact: Brokerages remain divided on the company’s growth outlook, particularly regarding the recovery in margins and the contribution of its new businesses
💡
Actionable Insight: 🔴 Bearish Risk: Regulatory scrutiny, profit decline, or sell-off risk may create near-term volatility.

Alkem Laboratories on Thursday reported a 14.37 per cent decline in consolidated net profit to Rs 667.13 crore during the September quarter on a rise in expenses.

The company had posted a net profit of Rs 779.11 crore in the corresponding period of the previous fiscal year.

Revenue from operations of the company rose to Rs 4,551.99 crore during the second quarter of FY27 from Rs 4,000.99 crore in the year-ago period, the company said in a regulatory filing.

Total expenses of the company also rose to Rs 3,721.55 crore during the quarter under review from Rs 3,208.85 crore a year earlier, it said.

The company's India business revenue grew 9.5 per cent year-on-year to Rs 3,027.5 crore during the quarter while its international business revenue was up 22.3 per cent to Rs 1,454 crore, the company said in a release.

📰
Official Publisher Attribution: This report is aggregated from Moneycontrol. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.
Read Original Full Coverage on Moneycontrol ↗
⚡
Get Breaking Stock Alerts & Q-Results on Telegram
Real-time 1200x675 image cards and financial filings delivered instantly.
Join @Zerolive_news ↗
Link copied to clipboard! ✅